Natural Killer Cells Therapeutics Market by Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2026

Abstract
Apex Market Research has published a new report titled ”Global Natural Killer Cells Therapeutics Market share, forecast data, In-Depth Analysis, and Forecast, 2020-2027”. According to the report, The global natural killer cells therapeutics market was valued at $1,402 million in 2018, and is projected to reach $5,096 million by 2026, registering a CAGR of 17.4% The report offers in-depth insights, revenue details, and other vital information regarding the global Natural Killer Cells Therapeutics market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.

Attractive Opportunities in the Natural Killer Cells Therapeutics market

The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Global Natural Killer Cells Therapeutics market report offers in-depth insights, revenue details, and other vital information regarding the global Natural Killer Cells Therapeutics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period.
It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest shareholder of Natural Killer Cells Therapeutics market. The major players operating into Natural Killer Cells Therapeutics Market include: Affimed N.V.
Celgene Corporation
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics BV
Innate Pharma S.A.
Nantkwest Inc.
Nkarta Therapeutics Inc.
Scope Of the Report
Report Parameters Details of Parameter
Market Size 2020-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value USD
Covered Segments Therapeutics, Application, End User
Region Covered North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)
This research report categorizes the Natural Killer Cells Therapeutics market to forecast revenues and analyze trends in each of the following submarkets:

By Therapeutics

  • NK Cell Therapies
  • NK Cell Directed Antibodies

By Application

  • Cancer 
  • Gastrointestinal Diseases
  • Immunoproliferative Disorders
  • Others

By End User

  • Research Centers & Institutes 
  • Hospitals
  • Others
By geography, this market has been segregated into five regions with revenue and growth rate of Natural Killer Cells Therapeutics from 2020 to 2027,
There are 13 chapters to put on view for Natural Killer Cells Therapeutics Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Natural Killer Cells Therapeutics Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 Natural Killer Cells Therapeutics Market Overview 1.1.1 Natural Killer Cells Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Natural Killer Cells Therapeutics Market Size and Analysis by Regions (2015-2019) 1.2.1 North America Natural Killer Cells Therapeutics Market Status and Outlook 1.2.2 EU Natural Killer Cells Therapeutics Market Status and Outlook 1.2.3 Japan Natural Killer Cells Therapeutics Market Status and Outlook 1.2.4 China Natural Killer Cells Therapeutics Market Status and Outlook 1.2.5 India Natural Killer Cells Therapeutics Market Status and Outlook 1.2.6 Southeast Asia Natural Killer Cells Therapeutics Market Status and Outlook 1.3 Global Natural Killer Cells Therapeutics Market Segment Therapeutics
1.3.1 Introduction
1.3.1.1 Market Estimates And Forecast 2015-2027
1.3.2 NK Cell Therapies
1.3.2.1 Market Estimates And Forecast By Country, 2015-2027
1.3.3 NK Cell Directed Antibodies
1.3.3.1 Market Estimates And Forecast By Country, 2015-2027
1.4 Global Natural Killer Cells Therapeutics Market Segment Application
1.4.1 Introduction
1.4.1.1 Market Estimates And Forecast 2015-2027
1.4.2 Cancer 
1.4.2.1 Market Estimates And Forecast By Country, 2015-2027
1.4.3 Gastrointestinal Diseases
1.4.3.1 Market Estimates And Forecast By Country, 2015-2027
1.4.4 Immunoproliferative Disorders
1.4.4.1 Market Estimates And Forecast By Country, 2015-2027
1.4.5 Others
1.4.5.1 Market Estimates And Forecast By Country, 2015-2027
1.5 Global Natural Killer Cells Therapeutics Market Segment End User
1.5.1 Introduction
1.5.1.1 Market Estimates And Forecast 2015-2027
1.5.2 Research Centers & Institutes 
1.5.2.1 Market Estimates And Forecast By Country, 2015-2027
1.5.3 Hospitals
1.5.3.1 Market Estimates And Forecast By Country, 2015-2027
1.5.4 Others
1.5.4.1 Market Estimates And Forecast By Country, 2015-2027
Chapter 2 Global Natural Killer Cells Therapeutics Competition Analysis by Players 2.1 Global Natural Killer Cells Therapeutics Market Size (Million USD) by Players (2015-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 Affimed N.V. 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Affimed N.V., Natural Killer Cells Therapeutics Revenue (Million USD) (2015-2019) 3.1.5 Recent Developments 3.2 Celgene Corporation 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Celgene Corporation, Natural Killer Cells Therapeutics Revenue (Million USD) (2015-2019) 3.2.5 Recent Developments 3.3 Fate Therapeutics 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Fate Therapeutics, Natural Killer Cells Therapeutics Revenue (Million USD) (2015-2019) 3.3.5 Recent Developments 3.4 Fortress Biotech 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Fortress Biotech, Natural Killer Cells Therapeutics Revenue (Million USD) (2015-2019) 3.4.5 Recent Developments 3.5 Glycostem Therapeutics BV 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Glycostem Therapeutics BV, Natural Killer Cells Therapeutics Revenue (Million USD)(2015-2019) 3.5.5 Recent Developments 3.6 Innate Pharma S.A. 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Innate Pharma S.A., Natural Killer Cells Therapeutics Revenue (Million USD)(2015-2019) 3.6.5 Recent Developments 3.7 Nantkwest Inc. 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Nantkwest Inc., Natural Killer Cells Therapeutics Revenue (Million USD)(2015-2019) 3.7.5 Recent Developments 3.8 Nkarta Therapeutics Inc. 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Nkarta Therapeutics Inc., Natural Killer Cells Therapeutics Revenue (Million USD) (2015-2019) 3.8.5 Recent Developments 3.9 Player 8 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Player 8, Natural Killer Cells Therapeutics Revenue (Million USD) (2015-2019) 3.9.5 Recent Developments 3.10 Player-9 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Player-9, Natural Killer Cells Therapeutics Revenue (Million USD) (2015-2019) 3.10.5 Recent Developments Chapter 4 Global Natural Killer Cells Therapeutics Market Size Type (2015-2019) 4.1 Global Natural Killer Cells Therapeutics Market Size by Type (2015-2019) Chapter 5 Global Natural Killer Cells Therapeutics Market Size Application (2015-2019) 5.1 Global Natural Killer Cells Therapeutics Market Size by Application (2015-2019) 5.2 Potential Application of Natural Killer Cells Therapeutics in Future 5.3 Top Consumer / End Users of Natural Killer Cells Therapeutics Chapter 6 North America Natural Killer Cells Therapeutics Development Status and Outlook 6.1 North America Natural Killer Cells Therapeutics Market Size (2015-2019) 6.2 North America Natural Killer Cells Therapeutics Market Size by Application (2015-2019) Chapter 7 EU Natural Killer Cells Therapeutics Development Status and Outlook 7.1 EU Natural Killer Cells Therapeutics Market Size (2015-2019) 7.2 EU Natural Killer Cells Therapeutics Market Size by Application (2015-2019) Chapter 8 Japan Natural Killer Cells Therapeutics Development Status and Outlook 8.1 Japan Natural Killer Cells Therapeutics Market Size (2015-2019) 8.2 Japan Natural Killer Cells Therapeutics Market Size by Application (2015-2019) Chapter 9 China Natural Killer Cells Therapeutics Development Status and Outlook 9.1 China Natural Killer Cells Therapeutics Market Size and Forecast (2015-2019) 9.2 China Natural Killer Cells Therapeutics Market Size by Application (2015-2019) Chapter 10 India Natural Killer Cells Therapeutics Development Status and Outlook 10.1 India Natural Killer Cells Therapeutics Market Size and Forecast (2015-2019) 10.2 India Natural Killer Cells Therapeutics Market Size by Application (2015-2019) Chapter 11 Southeast Asia Natural Killer Cells Therapeutics Development Status and Outlook 11.1 Southeast Asia Natural Killer Cells Therapeutics Market Size and Forecast (2015-2019) 11.2 Southeast Asia Natural Killer Cells Therapeutics Market Size by Application (2015-2019) Chapter 12 Market Forecast by Regions and Application (2020-2027) 12.1 Global Natural Killer Cells Therapeutics Market Size (Million USD) by Regions (2020-2027) 12.1. North America Natural Killer Cells Therapeutics Revenue and Growth Rate (2020-2027) 12.1.2 EU Natural Killer Cells Therapeutics Revenue and Growth Rate (2020-2027) 12.1.3 China Natural Killer Cells Therapeutics Revenue and Growth Rate (2020-2027) 12.1.4 Japan Natural Killer Cells Therapeutics Revenue and Growth Rate (2020-2027) 12.1.5 Southeast Asia Natural Killer Cells Therapeutics Revenue and Growth Rate (2020-2027) 12.1.6 India Natural Killer Cells Therapeutics Revenue and Growth Rate (2020-2027) 12.2 Global Natural Killer Cells Therapeutics Market Size by Application (2020-2027) Chapter 13 Natural Killer Cells Therapeutics Market Dynamics 13.1 Natural Killer Cells Therapeutics Market Opportunities 13.2 Natural Killer Cells Therapeutics Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 Natural Killer Cells Therapeutics Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 Natural Killer Cells Therapeutics Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
5600

1525

OUR CLIENT